Aldo-keto reductases 1B in endocrinology and metabolism

Frontiers in Pharmacology

Volumn 3 AUG, Issue , 2012, Pages

  Pastel, Emilie ^a   Pointud, Jean Christophe ^a   Volat, Fanny ^a   Martinez, Antoine ^a   Lefrançois Martinez, Anne Marie ^a  

^a UNIVERSITÉ CLERMONT AUVERGNE   (France)

Author keywords

Adipose tissue; Aldose reductases; Enterohepatic tissue; Metabolism; Prostaglandins

Indexed keywords

ALDO KETO REDUCTASE 1B; ALDO KETO REDUCTASE 1B1; ALDO KETO REDUCTASE 1B10; ALDO KETO REDUCTASE 1B3; ALDO KETO REDUCTASE 1B7; ALDO KETO REDUCTASE 1B8; ISOENZYME; MESSENGER RNA; RETINOID X RECEPTOR; UNCLASSIFIED DRUG;

ADIPOSE TISSUE; ADRENAL GLAND; ALDO KETO REDUCTASE 1B GENE; ALDO KETO REDUCTASE 1B1 GENE; ALDO KETO REDUCTASE 1B10 GENE; ALDO KETO REDUCTASE 1B3 GENE; ALDO KETO REDUCTASE 1B7 GENE; ALDO KETO REDUCTASE 1B8 GENE; ARTICLE; DETOXIFICATION; ENDOCRINOLOGY; ENZYME ACTIVITY; ENZYME METABOLISM; ENZYME REGULATION; ENZYME SPECIFICITY; GAIN OF FUNCTION MUTATION; GENE EXPRESSION REGULATION; GLUCOSE METABOLISM; HOMEOSTASIS; HUMAN; INTESTINE MUCOSA; LIPID PEROXIDATION; LIPOGENESIS; LIVER PARENCHYMA; LOSS OF FUNCTION MUTATION; MOLECULAR PHYLOGENY; NONHUMAN; PHYSIOLOGICAL PROCESS; PROTEIN EXPRESSION; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION; TISSUE DISTRIBUTION; TRANSCRIPTION REGULATION;

EID: 84866168092     PISSN: None     EISSN: 16639812     Source Type: Journal    
DOI: 10.3389/fphar.2012.00148     Document Type: Article

References (113)

1. Aida, K., Ikegishi, Y., Chen, J., Tawata, M., Ito, S., Maeda, S., and Onaya, T. (2000). Disruption of aldose reductase gene (Akr1b1) causes defect in urinary concentrating ability and divalent cation homeosta-sis. Biochem. Biophys. Res. Commun. 277,281-286.
2. Aigueperse, C., Martinez, A., Lefrancois-Martinez, A. M., Veyssière, G., and Jean, C. I. (1999). Cyclic AMP regulates expression of the gene coding for a mouse vas deferens protein related to the aldo-keto reductase superfamily in human and murine adrenocortical cells. J. Endocrinol. 160, 147-154.
3. Aigueperse, C., Val, P., Pacot, C., Darne, C., Lalli, E., Sassone-Corsi, P., Veyssière, G., Jean, C., and Martinez, A. (2001). SF-1(steroidogenic factor-1), C/EBPbeta (CCAAT/enhancer binding protein), and ubiquitous transcription factors NF1 (nuclear factor 1) and Sp1 (selective promoter factor 1) are required for regulation of the mouse aldose reductase-like gene (AKR1B7) expression in adrenocortical cells. Mol. Endocrinol. 15, 93-111.
4. Ailhaud, G., Grimaldi, P., and Négrel, R. (1992). Cellular and molecular aspects of adipose tissue development. Annu. Rev. Nutr. 12, 207-233.
5. Barski, O. A., Tipparaju, S. M., and Bhatnagar, A. (2008). The aldo-keto reductase superfamily and its role in drug metabolism and detoxification. DrugMetab. Rev. 40, 553-624.
6. Bohren, K. M., Bullock, B., Wermuth, B., and Gabbay, K. H. (1989).The aldo-keto reductase superfamily. cDNAs and deduced amino acid sequences of human aldehyde and aldose reductases. J. Biol. Chem. 264, 9547-9551.
7. Bohren, K. M., Grimshaw, C. E., and Gabbay, K. H. (1992). Catalytic effectiveness of human aldose reductase. Critical role of C-terminal domain. J. Biol. Chem. 267, 20965-20970.
8. Brownlee, M. (2001). Biochemistry and molecular cell biology of diabetic complications. Nature 414,813-820.
9. Brunskill, E. W., Sequeira-Lopez, M. L. S.,Pentz, E. S., Lin, E.,Yu, J.,Aronow, B. J., Potter, S. S., and Gomez, R. A. (2011). Genes that confer the identity of the renin cell. J. Am. Soc. Nephrol. 22,2213-2225.
10. Burczynski, J. M., Hayes, J. R., Longhurst, P. A., and Colby, H.D. (1999). Species differences in adrenal lipid peroxidation: role of alpha-tocopherol. Free Radic. Biol. Med. 26,987-991.
11. Cao, D., Fan, S. T., and Chung, S. S. (1998). Identification and characterization of a novel human aldose reductase-like gene. J. Biol. Chem. 273,11429-11435.
12. Chajès, V., Cambot, M., Moreau, K., Lenoir, G. M., and Joulin, V. (2006). Acetyl-CoA carboxylase alpha is essential to breast cancer cell survival. Cancer Res. 66, 5287-5294.
13. Chen, G., Liang, G., Ou, J., Goldstein, J. L., and Brown, M. S. (2004). Central role for liver X receptor in insulin-mediated activation of Srebp-1c transcription and stimulation of fatty acid synthesis in liver. Proc. Natl. Acad. Sci. U.S.A. 101, 11245-11250.
14. Clyne, C. D., Speed, C. J., Zhou, J., and Simpson, E. R. (2002). Liver receptor homologue-1 (LRH-1) regulates expression of aromatase in preadipocytes. J. Biol. Chem. 277, 20591-20597.
15. de Reyniès, A., Assié, G., Rickman, D. S., Tissier, F., Groussin, L., René-Corail, F., Dousset, B., Bertagna, X., Clauser, E., and Bertherat, J. (2009). Gene expression profiling reveals a new classification of adrenocor-tical tumors and identifies molecular predictors of malignancy and survival. J. Clin. Oncol. 27, 1108-1115.
16. Derry, J. M. J., Zhong, H., Molony, C., MacNeil, D., Guhathakurta, D., Zhang, B., Mudgett, J., Small, K., El Fertak, L., Guimond, A., Selloum, M., Zhao, W., Champy, M. F., Monassier, L., Vogt, T., Cully, D., Kasarskis, A., and Schadt, E. E. (2010). Identification of genes and networks driving cardiovascular and metabolic phenotypes in a mouse F2 intercross. PLoS ONE 5, e14319. doi:10.1371/journal.pone.0014319
17. Donohue, P. J., Alberts, G. F., Hampton, B. S., and Winkles, J. A. (1994). A delayed-early gene activated by fibroblast growth factor-1 encodes a protein related to aldose reductase. J. Biol. Chem. 269, 8604-8609.
18. Ebert, B., Kisiela, M., Wsól, V., and Maser, E. (2011). Proteasome inhibitors MG-132 and bortezomib induce AKR1C1,AKR1C3,AKR1B1, and AKR1B10 in human colon cancer cell lines SW-480 and HT-29. Chem. Biol. Interact. 191,239-249.
19. Endo, S., Matsunaga, T., Fujita, A., Kuragano, T., Soda, M., Sundaram, K., Dhagat, U., Tajima, K., El-Kabbani, O., and Hara, A. (2011). Activation of aldo-keto reductase family member 1B14 (AKR1B14) by bile acids: activation mechanism and bile acid-binding site. Biochimie 93, 1476-1486.
20. Endo, S., Matsunaga, T., Fujita, A., Tajima, K., El-Kabbani, O., and Hara, A. (2010a). Rat aldose reductase-like protein (AKR1B14) efficiently reduces the lipid peroxidation product 4-oxo-2-nonenal. Biol. Pharm. Bull. 33, 1886-1890.
21. Endo, S., Matsunaga, T., Kuragano, T., Ohno, S., Kitade, Y., Tajima, K., El-Kabbani, O., and Hara, A. (2010b). Properties and tissue distribution of a novel aldo-keto reductase encoding in a rat gene (Akr1b10). Arch. Biochem. Biophys. 503, 230-237.
22. Endo, S., Matsunaga, T., Mamiya, H., Hara, A., Kitade, Y., Tajima, K., and El-Kabbani, O. (2009a). Characterization of a rat NADPH-dependentaldo-keto reductase (AKR1B13) induced by oxidative stress. Chem. Biol. Interact. 178, 151-157.
23. Endo, S., Matsunaga, T., Mamiya, H., Ohta, C., Soda, M., Kitade, Y., Tajima, K., Zhao, H.-T., El-Kabbani, O., and Hara, A. (2009b). Kinetic studies of AKR1B10, human aldose reductase-like protein: endogenous substrates and inhibition by steroids. Arch. Biochem. Biophys. 487, 1-9.
24. Fonseca-Alaniz, M. H., Takada, J., Alonso-Vale, M. I. C., and Lima, F. B. (2007). Adipose tissue as an endocrine organ: from theory to practice.J. Pediatr. (Rio. J.)83,S192-S203.
25. Frühbeck, G. (2008). Overview of adipose tissue and its role in obesity and metabolic disorders. Methods Mol. Biol. 456,1-22.
26. Fujimori, K., Aritake, K., and Urade, Y (2007). A novel pathway to enhance adipocyte differentiation of 3T3-L1 cells by up-regulation of lipocalin-type prostaglandin D syn-thase mediated by liver X receptor-activated sterol regulatory element-binding protein-1c. J. Biol. Chem. 282,18458-18466.
27. Fujimori, K., Ueno, T., Nagata, N., Kashiwagi, K., Aritake, K., Amano, E, and Urade, Y (2010). Suppression of adipocyte differentiation by aldo-keto reductase 1B3 acting as prostaglandin F2alpha synthase. J. Biol. Chem. 285, 8880-8886.
28. Fujitani, Y., Aritake, K., Kanaoka, Y., Goto, T., Takahashi, N., Fujimori, K., and Kawada, T. (2010). Pronounced adipogenesis and increased insulin sensitivity caused by overproduction of prostaglandin D2 in vivo. FEBS J. 277, 1410-1419.
29. Fukumoto, S.-I., Yamauchi, N., Moriguchi, H., Hippo, Y., Watanabe, A., Shibahara, J., Taniguchi, H., Ishikawa, S., Ito, H., Yamamoto, S., Iwanari, H., Hironaka, M., Ishikawa, Y., Niki, T., Sohara, Y., Kodama, T., Nishimura, M., Fukayama, M., Dosaka-Akita, H., and Aburatani, H. (2005). Overexpression of the aldo-keto reductase family protein AKR1B10 is highly correlated with smokers' non-small cell lung carcinomas. Clin. Cancer Res. 11, 1776-1785.
30. Ge, X., Yin, L., Ma, H., Li, T., Chiang, J. Y L., and Zhang, Y (2011). Aldo-keto reductase 1B7 is a target gene of FXR and regulates lipid and glucose homeostasis. J. Lipid Res. 52, 1561-1568.
31. Gregoire, F. M., Smas, C. M., and Sul, H. S. (1998). Understanding adipocyte differentiation. Physiol. Rev. 78, 783-809.
32. Gui, T., Tanimoto, T., Kokai, Y., and Nishimura, C. (1995). Presence of a closely related subgroup in the aldo-keto reductase family of the mouse. Eur. J. Biochem. 227,448-453.
33. Henry, S. L., Bensley, J. G., Wood-Bradley, R. J., Cullen-McEwen, L. A., Bertram, J. F., and Armitage, J. A. (2012). White adipocytes: more than just fat depots. Int. J. Biochem. Cell Biol. 44, 435-440.
34. Heringlake, S., Hofdmann, M., Fiebeler, A., Manns, M. P., Schmiegel, W., and Tannapfel, A. (2010). Identification and expression analysis of the aldo- ketoreductase1-B10 gene in primary malignant liver tumours. J. Hepatol. 52, 220-227.
35. Ho, H. T., Chung, S. K., Law, J. W., Ko, B. C., Tam, S. C., Brooks, H. L., Knepper, M. A., and Chung, S. S. (2000). Aldose reductase-deficient mice develop nephrogenic diabetes insipidus. Mol. Cell. Biol. 20, 5840-5846.
36. Ho, H. T., Jenkins, N. A., Copeland, N. G., Gilbert, D.J., Winkles, J. A., Louie, H. W., Lee, F. K., Chung, S. S., and Chung, S. K. (1999). Comparisons of genomic structures and chromosomal locations of the mouse aldose reductase and aldose reductase-like genes. Eur. J. Biochem. 259,726-730.
37. Horton, J. D., Goldstein, J. L., and Brown,M.S. (2002).SREBPs:activators of the complete program of cholesterol and fatty acid synthesis in the liver.J. Clin. Invest. 109,1125-1131.
38. Hsu, D. K., Guo, Y., Peifley, K. A., and Winkles, J. A. (1997). Differential control of murine aldose reductase and fibroblast growth factor (FGF)-regulated-1 gene expression in NIH 3T3 cells by FGF-1 treatment and hyperosmotic stress. Biochem. J. 328(Pt 2), 593-598.
39. Hylemon, P. B., Zhou, H., Pandak, W. M., Ren, S., Gil, G., and Dent, P. (2009). Bile acids as regulatory molecules. J. Lipid Res. 50, 1509-1520.
40. Hyndman, D., Bauman, D. R., Heredia, V. V., and Penning, T. M. (2003). The aldo-keto reductase superfam-ily homepage. Chem. Biol. Interact. 143-144,621-631.
41. Hyndman, D. J., and Flynn, T. G. (1998). Sequence and expression levels in human tissues of a new member of the aldo-keto reductase family. Biochim. Biophys. Acta 1399, 198-202.
42. Jez, J. M., Flynn, T. G., and Penning, T. M. (1997). A new nomenclature for the aldo-keto reductase superfamily. Biochem. Pharmacol. 54, 639-647.
43. Joshi, A., Rajput, S., Wang, C., Ma, J., and Cao, D. (2010). Murine aldo-keto reductase family 1 subfamily B: identification of AKR1B8 as an ortholog of human AKR1B10. Biol. Chem. 391,1371-1378.
44. Kabututu, Z., Manin, M., Pointud, J.-C., Maruyama, T., Nagata, N., Lambert, S., Lefrançois-Martinez, A.-M., Martinez, A., and Urade, Y. (2009). Prostaglandin F2alpha synthase activities of aldo-keto reductase 1B1, 1B3, and 1B7. J. Biochem. 145, 161-168.
45. Kim, T.-H., Kim, H., Park, J.-M., Im, S.-S., Bae, J.-S., Kim, M.-Y., Yoon, H.-G., Cha, J.-Y., Kim, K.-S., and Ahn, Y.-H. (2009). Interrelationship between liver X receptor alpha, sterol regulatory element-binding protein-1c, peroxisome proliferator-activated receptor gamma, and small heterodimer partner in the tran-scriptional regulation of glucoki-nase gene expression in liver. / Biol. Chem. 284,15071-15083.
46. Lambert-Langlais, S., Pointud, J.-C., Lefrançois-Martinez, A.-M., Volat, E, Manin, M., Coudore, E, Val, P., Sahut-Barnola, I., Ragazzon, B., Louiset, E., Delarue, C., Lefeb-vre, H., Urade, Y., and Martinez, A.(2009). Aldo keto reductase 1B7 and prostaglandin F2α are regulators of adrenal endocrine functions. PLoS ONE 4, e7309. doi:10.1371/journal.pone.0007309
47. Lau, E. T., Cao, D., Lin, C., Chung, S. K., and Chung, S. S. (1995). Tissue-specific expression of two aldose reductase-like genes in mice: abundant expression of mouse vas deferens protein and fibroblast growth factor-regulated protein in the adrenal gland. Biochem. J. 312(Pt 2), 609-615.
48. Lefrançois-Martinez, A.-M., Bertherat, J., Val, P., Tournaire, C., Gallo-Payet, N., Hyndman, D., Veyssière, G., Bertagna, X., Jean, C., and Martinez, A. (2004). Decreased expression of cyclic adenosine monophosphate-regulated aldose reductase (AKR1B1) is associated with malignancy in human sporadic adrenocortical tumors. / Clin. Endocrinol. Metab. 89, 3010-3019.
49. Lefrancois-Martinez, A. M., Tournaire, C., Martinez, A., Berger, M., Daoudal, S., Tritsch, D., Veyssière, G., and Jean, C. (1999). Product of side-chain cleavage of cholesterol, isocaproaldehyde, is an endogenous specific substrate of mouse vas deferens protein, an aldose reductase-like protein in adrenocortical cells. J. Biol. Chem. 274, 32875-32880.
50. Libè, R., Fratticci, A., and Bertherat, J. (2007). Adrenocortical cancer: pathophysiology and clinicalmanagement. Endocr. Relat. Cancer 14,13-28.
51. Liu, L., and Clipstone, N. A. (2007). Prostaglandin F2alpha inhibits adipocyte differentiation via a G alpha q-calcium-calcineurin-dependent signaling pathway. J. Cell. Biochem. 100, 161-173.
52. Liu, M.-J., Takahashi, Y., Wada, T., He, J., Gao, J., Tian, Y., Li, S., and Xie, W. (2009). The aldo-keto reductase Akr 1b7 gene is a common transcrip-tional target of xenobiotic receptors pregnane X receptor and constitutive androstane receptor. Mol. Pharmacol. 76, 604-611.
53. Liu, Z., Yan, R., Al Salman, A., Shen, Y., Bu, Y., Ma, J., Luo, D. X., Huang, C., Jiang, Y.,Wilber, A., Mo, Y.Y., Huang, M. C., Zhao, Y., and Cao, D. (2012). Epidermal growth factor induces tumour marker AKR1B10 expression through activator protein-1 signalling in hepatocellular carcinoma cells. Biochem. J. 442, 273-282.
54. Ma, J., Yan, R., Zu, X., Cheng, J.-M., Rao, K., Liao, D.-F., and Cao, D. (2008). Aldo-keto reductase family 1 B10 affects fatty acid synthesis by regulating the stability of acetyl-CoA carboxylase-alpha in breast cancer cells.J. Biol. Chem. 283, 3418-3423.
55. Ma, K., Saha, P. K., Chan, L., and Moore, D. D. (2006). Farnesoid X receptor is essential for normal glucose homeostasis. J. Clin. Invest. 116, 1102-1109.
56. MacLeod, A. K., Kelly, V. P., Higgins, L. G., Kelleher, M. O., Price, S. A., Bigley, A. L., Betton, G. R., and Hayes, J. D. (2010). Expression and localization of rat aldo-keto reductases and induction of the 1B13 and 1D2 isoforms by phenolic antioxidants. DrugMetab. Dispos. 38,341-346.
57. Madore, E., Harvey, N., Parent, J., Chapdelaine, P., Arosh, J. A., and Fortier, M. A. (2003). An aldose reductase with 20 alpha-hydroxysteroid dehydrogenase activity is most likely the enzyme responsible for the production of prostaglandin f2 alpha in the bovine endometrium. J. Biol. Chem. 278, 11205-11212.
58. Martin, H.-J., Breyer-Pfaff, U., Wsól, V., Venz, S., Block, S., and Maser, E. (2006). Purification and characterization of akr1b10 from human liver: role in carbonyl reduction of xenobiotics. DrugMetab. Dispos. 34, 464-470.
59. Martin, H.-J., and Maser, E. (2009). Role of human aldo-keto-reductase AKR1B10 in the protection againsttoxic aldehydes. Chem. Biol. Interact. 178,145-150.
60. Martinez, A., Aigueperse, C., Val, P., Dussault, M., Tournaire, C., Berger, M., Veyssière, G., Jean, C., and Lefrançois Martinez, A. (2001). Physiological functions and hormonal regulation of mouse vas def-erens protein (AKR1B7) in steroido-genic tissues. Chem. Biol. Interact. 130-132,903-917.
61. Martinez, A., Val, P., Sahut-Barnola, I., Aigueperse, C., Veyssière, G., and Lefrançois-Martinez, A.-M. (2003). Steroidogenic factor-1 controls the aldose reductase akr1b7 gene promoter in transgenic mice through an atypical binding site. Endocrinology 144,2111-2120.
62. Matsunaga, T., Wada, Y., Endo, S., Soda, M., El-Kabbani, O., and Hara, A. (2012). Aldo-keto reductase 1B 10 and its role in proliferation capacity of drug-resistant cancers. Front. Pharmacol. 3:5. doi:10.3389/fphar.2012.00005
63. Matsuura, K., Deyashiki, Y., Bunai, Y., Ohya, I., and Hara, A. (1996). Aldose reductase is a major reductase for isocaproaldehyde, a product of side-chain cleavage of cholesterol, in human and animal adrenal glands. Arch. Biochem. Biophys. 328, 265-271.
64. Moraes, R. C.,Blondet,A.,Birkenkamp-Demtroeder, K., Tirard, J., Orntoft, T. F., Gertler, A., Durand, P., Naville, D., and Begeot, M. (2003). Study of the alteration of gene expression in adipose tissue of diet-induced obese mice by microarray and reverse transcription-polymerase chain reaction analyses. Endocrinology 144, 4773-4782.
65. Nagata, N., Kusakari, Y., Fukunishi, Y., Inoue, T., and Urade, Y (2011). Catalytic mechanism of the primary human prostaglandin F2α syn-thase, aldo-keto reductase 1B1 -prostaglandin D2 synthase activity in the absence of NADP(H). FEBS J. 278,1288-1298.
66. Nishinaka, T., Miura, T., Okumura, M., Nakao, F., Nakamura, H., and Terada, T. (2011). Regulation of aldo-keto reductase AKR1B10 gene expression: involvement of transcription factor Nrf2. Chem. Biol. Interact. 191,185-191.
67. Nishinaka, T., and Yabe-Nishimura, C. (2005). Transcription factor Nrf2 regulates promoter activity of mouse aldose reductase (AKR1B3) gene. J. Pharmacol. Sci. 97, 43-51.
68. O'Connor, T., Ireland, L. S., Harrison, D. J., and Hayes, J. D. (1999). Major differences exist in the function and tissue-specific expression ofhuman aflatoxin B1 aldehyde reductase and the principal human aldo-keto reductase AKR1 family members. Biochem. J. 343(Pt 2), 487-504.
69. Pailhoux, E. A., Martinez, A., Veyssiere, G. M., and Jean, C. G. (1990). Androgen-dependent protein from mouse vas deferens. cDNA cloning and protein homology with the aldo-keto reductase superfamily. J. Biol. Chem. 265, 19932-19936.
70. Postic, C., and Girard, J. (2008). Contribution of de novo fatty acid synthesis to hepatic steatosis and insulin resistance: lessons from genetically engineered mice.J. Clin. Invest. 118, 829-838.
71. Qiu, L., Lin, J., Xu, F., Gao, Y., Zhang, C., Liu, Y., Luo, Y., and Yang, J. Y. (2012). Inhibition of aldose reductase activates hepatic peroxisome proliferator-activated receptor-α and ameliorates hepatosteatosis in diabetic db/db mice. Exp. Diabetes Res. 2012, 789730.
72. Qiu, L., Wu, X., Chau, J. F. L., Szeto, I. Y. Y., Tam, W. Y., Guo, Z., Chung, S. K., Oates, P. J., Chung, S. S. M., and Yang, J. Y (2008). Aldose reductase regulates hepatic peroxisome proliferator-activated receptor alpha phosphorylation and activity to impact lipid homeostasis. J. Biol. Chem. 283, 17175-17183.
73. Ragazzon, B., Lefrançois-Martinez, A.-M., Val, P., Sahut-Barnola, I., Tournaire, C., Chambon, C., Gachancard-Bouya, J.-L., Begue, R.-J., Veyssière, G., and Martinez, A. (2006). Adrenocorticotropin-dependent changes in SF-1/DAX-1 ratio influence steroidogenic genes expression in a novel model of glucocorticoid-producing adrenocortical cell lines derived from targeted tumorigenesis. Endocrinology 147, 1805-1818.
74. Ragolia, L., Palaia, T., Hall, C. E., Mae-saka, J. K., Eguchi, N., and Urade, Y. (2005). Accelerated glucose intolerance, nephropathy, and atherosclerosis in prostaglandin D2 synthase knock-out mice. J. Biol. Chem. 280, 29946-29955.
75. Rajkumar, T., Vijayalakshmi, N., Gopal, G., Sabitha, K., Shirley, S., Raja, U. M., and Ramakrishnan, S. A. (2010). Identification and validation of genes involved in gastric tumorigenesis. Cancer Cell Int. 10,45.
76. Ramsay, R. G., Ciznadija, D., Vanevski, M., and Mantamadiotis, T. (2003). Transcriptional regulation of cyclo-oxygenase expression: three pillars of control. Int. J. Immunopathol. Pharmacol. 16, 59-67.
77. Rangasamy, T., Cho, C. Y., Thimmu-lappa, R. K., Zhen, L., Srisuma, S. S.,Kensler, T. W., Yamamoto, M., Petra-che, I., Tuder, R. M., and Biswal, S. (2004). Genetic ablation of Nrf2 enhances susceptibility to cigarette smoke-induced emphysema in mice. J. Clin. Invest. 114, 1248-1259.
78. Reginato, M. J., Krakow, S. L., Bailey, S. T., and Lazar, M. A. (1998). Prostaglandins promote and block adipogenesis through opposing effects on peroxisome proliferator-activated receptor gamma. J. Biol. Chem. 273,1855-1858.
79. Roglans, N., Vilà, L., Farré, M., Ale-gret, M., Sánchez, R. M., Vázquez-Carrera, M., and Laguna, J. C. (2007). Impairment of hepatic Stat-3 activation and reduction of PPA-Ralpha activity in fructose-fed rats. Hepatology 45, 778-788.
80. Rosen, E. D., Sarraf, P., Troy, A. E., Brad-win, G., Moore, K., Milstone, D. S., Spiegelman, B. M., and Mortensen, R. M. (1999). PPAR gamma is required for the differentiation of adipose tissue in vivo and in vitro. Mol. Cell 4,611-617.
81. Rosen, E. D., and Spiegelman, B. M. (2000). Molecular regulation of adipogenesis. Annu. Rev. Cell Dev. Biol. 16, 145-171.
82. Ruiz, F. X., Moro, A., Gallego, O., Ardèvol, A., Rovira, C., Petrash, J. M., Parés, X., and Farrés, J. (2011). Human and rodent aldo-keto reductases from the AKR1B subfamily and their specificity with reti-naldehyde. Chem. Biol. Interact. 191, 199-205.
83. Salabei, J. K., Li, X.-P., Petrash, J. M., Bhatnagar, A., and Barski, O. A. (2011). Functional expression of novel human and murine AKR1B genes. Chem. Biol. Interact. 191, 177-184.
84. Schmidt, D. R., and Mangelsdorf, D. J. (2008). Nuclear receptors of the enteric tract: guarding the frontier. Nutr. Rev. 66, S88-S97.
85. Schmidt, D. R., Schmidt, S., Holmstrom, S. R., Makishima, M., Yu, R. T., Cummins, C. L., Mangelsdorf, D. J., and Kliewer, S. A. (2011). AKR1B7 is induced by the farnesoid X receptor and metabolizes bile acids. J. Biol. Chem. 286,2425-2432.
86. Serrero, G., Lepak,N. M., and Goodrich, S. P. (1992). Paracrine regulation of adipose differentiation by arachido-nate metabolites: prostaglandin F2 alpha inhibits early and late markers of differentiation in the adipogenic cell line 1246. Endocrinology 131, 2545-2551.
87. Shen, Y., Zhong, L., Johnson, S., and Cao, D. (2011). Human aldo-keto reductases 1B1 and 1B10: acompar-ative study on their enzyme activitytoward electrophilic carbonyl compounds. Chem. Biol. Interact. 191, 192-198.
88. Sirianni, R., Seely, J. B., Attia, G., Stocco, D. M., Carr, B. R., Pezzi, V., and Rainey, W. E. (2002). Liver receptor homologue-1 is expressed in human steroidogenic tissues and activates transcription of genes encoding steroidogenic enzymes. J. Endocrinol. 174, R13-R17.
89. Spite, M., Baba, S. P., Ahmed, Y., Barski, O. A., Nijhawan, K., Petrash, J. M., Bhatnagar, A., and Srivas-tava, S. (2007). Substrate specificity and catalytic efficiency of aldo-keto reductases with phospho-lipid aldehydes. Biochem. J. 405, 95-105.
90. Srivastava, S., Harter, T. M., Chandra, A., Bhatnagar, A., Srivastava, S. K., and Petrash, J. M. (1998). Kinetic studies of FR-1, a growth factor-inducible aldo-keto reductase. Biochemistry 37, 12909-12917.
91. Stout, M. D., Bodes, E., Schoonhoven, R., Upton, P. B., Travlos, G. S., and Swenberg, J. A. (2008). Toxic-ity, DNA binding, and cell proliferation in male F344 rats following short-term gavage exposures to trans-2-hexenal. Toxicol. Pathol. 36, 232-246.
92. Tanaka, T., Yoshida, N., Kishimoto, T., and Akira, S. (1997). Defective adipocyte differentiation in mice lacking the C/EBPbeta and/or C/EBPdelta gene. EMBO J. 16, 7432-7443.
93. Tang, Q.-Q., Zhang, J.-W., and Daniel Lane, M. (2004). Sequential gene promoter interactions by C/EBPbeta, C/EBPalpha, and PPARgamma during adipogenesis. Biochem. Biophys. Res. Commun. 318,213-218.
94. Tirard, J., Gout, J., Lefrançois-Martinez, A.-M., Martinez, A., Begeot, M., and Naville, D. (2007). A novel inhibitory protein in adipose tissue, the aldo-keto reductase AKR1B7: its role in adipogenesis. Endocrinology 148, 1996-2005.
95. Tontonoz, P., Hu, E., and Spiegelman, B. M. (1994). Stimulation of adipogenesis in fibroblasts by PPAR gamma2, a lipid-activated transcription factor. Cell 79, 1147-1156.
96. Trayhurn, P., and Beattie, J. H. (2001). Physiological role of adipose tissue: white adipose tissue as an endocrine and secretory organ. Proc. Nutr. Soc. 60, 329-339.
97. Val, P., Aigueperse, C., Ragazzon, B., Veyssière, G., Lefrançois-Martinez, A.-M., and Martinez, A. (2004). Adrenocorticotropin/3'5'-cyclic AMP-mediated transcription of the scavenger akr1-b7 gene in adrenocortical cells is dependent on three functionally distinct steroidogenic factor-1-responsive elements. Endocrinology 145, 508-518.
98. Val, P., Martinez, A., Sahut-Barnola, I., Jean, C., Veyssière, G., and Lefrançois-Martinez, A.-M. (2002). A 77-base pair LINE-like sequence elicits androgen-dependent mvdp/akr1-b7 expression in mouse vas deferens, but is dispensable for adrenal expression in rats. Endocrinology 143, 3435-3448.
99. Varady, J., Eder, K., and Ringseis, R. (2011). Dietary oxidized fat activates the oxidative stress-responsive transcription factors NF-ΚB and Nrf2 in intestinal mucosa of mice. Eur. J. Nutr. 50, 601-609.
100. Vázquez-Vela, M. E. F., Torres, N., and Tovar, A. R. (2008). White adipose tissue as endocrine organ and its role in obesity. Arch. Med. Res. 39, 715-728.
101. Volat, F. E., Pointud, J. C., Pastel, E., Morio, B., Sion, B., Hamard, G., Guichardant, M., Colas, R., Lefrançois, A. M., and Martinez, A. (2012). Depressed levels of PGF2α in mice lacking Akr1b7 increase basal adiposity and predispose to diet-induced obesity. Diabetes 61 (in press).
102. Volle, D. H., Repa, J. J., Mazur, A., Cummins, C. L., Val, P., Henry-Berger, J., Caira, F., Veyssière, G., Mangels-dorf, D. J., and Lobaccaro, J.-M. A. (2004). Regulation of the aldo-keto reductase gene akr1b7 by the nuclear oxysterol receptor LXRalpha (liver X receptor-alpha) in the mouse intestine: putative role of LXRs in lipid detoxification processes. Mol. Endocrinol. 18, 888-898.
103. Wang, C., Yan, R., Luo, D., Watabe, K., Liao, D.-F., and Cao, D. (2009). Aldo-keto reductase family 1 member B10 promotes cell survival by regulating lipid synthesis and eliminating carbonyls.J. Biol. Chem. 284, 26742-26748.
104. Wang, N. D., Finegold, M. J., Bradley, A., Ou, C. N., Abdelsayed, S. V., Wilde, M. D., Taylor, L. R., Wilson, D. R., and Darlington, G. J. (1995). Impaired energy homeostasis in C/EBP alpha knockout mice. Science 269, 1108-1112.
105. Wu,Z., Rosen, E. D., Brun, R., Hauser, S., Adelmant, G., Troy, A. E., McKeon, C., Darlington, G. J., and Spiegelman, B. M. (1999). Cross-regulation of C/EBP alpha and PPAR gamma controls the transcriptional pathway of adipogenesis and insulin sensitivity. Mol. Cell 3, 151-158.
106. Yamagata, K., Daitoku, H., Shimamoto, Y., Matsuzaki, H., Hirota, K., Ishida, J., and Fukamizu, A. (2004). Bile acids regulate gluconeogenic gene expression via small het-erodimer partner-mediated repression of hepatocyte nuclear factor 4 and Foxo1. J. Biol. Chem. 279, 23158-23165.
107. Yamaoka, T., Nishimura, C., Yamashita, K., Itakura, M., Yamada, T., Fuji-moto, J., and Kokai, Y. (1995). Acute onset of diabetic pathological changes in transgenic mice with human aldose reductase cDNA. Dia-betologia 38,255-261.
108. Yan, R., Zu, X., Ma, J., Liu, Z., Adeyanju, M., and Cao, D. (2007). Aldo-keto reductase family 1 B10 gene silencing results in growth inhibition of colorectal cancer cells: implication for cancer intervention. Int. J. Cancer 121,2301-2306.
109. Yoshitake, H., Takahashi, M., Ishikawa, H., Nojima, M., Iwanari, H., Watan-abe, A., Aburatani, H., Yoshida, K., Ishi, K., Takamori, K., Ogawa, H., Hamakubo, T., Kodama, T., and Araki, Y. (2007). Aldo-keto reductase family 1, member B10 in uterine carcinomas: a potential risk factor of recurrence after surgical therapy in cervical cancer. Int. J. Gynecol. Cancer 17, 1300-1306.
110. Zhang, Y., and Edwards, P. A. (2008). FXR signaling in metabolic disease. FEBS Lett. 582, 10-18.
111. Zhang, Y., Lee, F. Y., Barrera, G., Lee, H., Vales, C., Gonzalez, F. J., Will-son, T.M.,and Edwards,P.A. (2006). Activation of the nuclear receptor FXR improves hyperglycemia and hyperlipidemia in diabetic mice. Proc. Natl. Acad. Sci. U.S.A. 103, 1006-1011.
112. Zhong, L., Liu, Z., Yan, R., Johnson, S., Zhao, Y., Fang, X., and Cao, D. (2009). Aldo-keto reductase family 1 B10 protein detoxifies dietary and lipid-derived alpha, beta-unsaturated carbonyls at physiological levels. Biochem. Biophys. Res. Commun. 387, 245-250.
113. Zollner, G., Marschall, H.-U., Wagner, M., and Trauner, M. (2006). Role of nuclear receptors in the adaptive response to bile acids and cholestasis: pathogenetic and therapeutic considerations. Mol. Pharm. 3,231-251.